KIMBERLY RODDY: Open Payments
NPI 1467908970 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,085 in 161 payments from 27 companies in 2025. Trend: 2023 $2,951 · 2024 $2,568 · 2025 $3,085
Food & beverage: $3,085
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 35 | $583 |
| AstraZeneca Pharmaceuticals LP | 20 | $368 |
| GENZYME CORPORATION | 11 | $308 |
| JAZZ PHARMACEUTICALS INC. | 8 | $212 |
| Insmed, Inc. | 11 | $203 |
| Regeneron Healthcare Solutions, Inc. | 10 | $192 |
| Verona Pharma, Inc. | 8 | $156 |
| Genentech USA, Inc. | 9 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $138 |
| Viatris Specialty LLC | 5 | $101 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, XYWAV, Arikayce, Xolair, Ohtuvayre, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
